Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

Erstveröffentlichung
2019Authors
Ray-Coquard, I.
Pautier, P.
Pignata, S.
Perol, D.
Gonzalez-Martin, A.
Wissenschaftlicher Artikel
Published in
New England Journal of Medicine ; 381 (2019), 25. - S. 2416-2428. - ISSN 0028-4793. - eISSN 1533-4406
Link to publication
https://dx.doi.org/10.1056/NEJMoa1911361Institutions
UKU. Klinik für Frauenheilkunde und GeburtshilfeSubject headings
[Free subject headings]: TRIAL GROUPS REQUIREMENTS | DOUBLE-BLIND | EUROPEAN NETWORK | ACADEMIC GROUPS | THERAPY | CARCINOMA | SURVIVAL | OUTCOMES | WOMEN[DDC subject group]: DDC 610 / Medicine & health